Article
Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System.
The Journal of infectious diseases - 15 May 2015
Liu Jessica, Tseng Tai-Chung, Yang Hwai-I, Lee Mei-Hsuan, Batrla-Utermann Richard, Jen Chin-Lan, Lu Sheng-Nan, Wang Li-Yu, You San-Lin, Chen Pei-Jer, Chen Chien-Jen, Kao Jia-Horng
Abstract excerpt
BACKGROUND: Hepatitis B virus (HBV) surface antigen (HBsAg) seroclearance is the ultimate serological end point in chronic hepatitis B. This study aimed to develop and validate a prediction score for spontaneous HBsAg seroclearance in HBV e antigen (HBeAg)-negative patients with chronic hepatitis B due to HBV genotype B or C. METHODS: The development cohort included 2491 untreated participants from the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
